Low J, Jerak J, Tortorici M, McCallum M, Pinto D, Cassotta A
Science. 2022; 377(6607):735-742.
PMID: 35857703
PMC: 9348755.
DOI: 10.1126/science.abq2679.
Tang Y, Sun J, Yuan Y, Yao F, Zheng B, Yang G
BMC Infect Dis. 2022; 22(1):10.
PMID: 34983429
PMC: 8724638.
DOI: 10.1186/s12879-021-07010-w.
Pinto D, Sauer M, Czudnochowski N, Low J, Tortorici M, Housley M
Science. 2021; 373(6559):1109-1116.
PMID: 34344823
PMC: 9268357.
DOI: 10.1126/science.abj3321.
Sauer M, Tortorici M, Park Y, Walls A, Homad L, Acton O
Nat Struct Mol Biol. 2021; 28(6):478-486.
PMID: 33981021
DOI: 10.1038/s41594-021-00596-4.
Sauer M, Tortorici M, Park Y, Walls A, Homad L, Acton O
bioRxiv. 2021; .
PMID: 33398277
PMC: 7781312.
DOI: 10.1101/2020.12.29.424482.
Particulate multivalent presentation of the receptor binding domain induces protective immune responses against MERS-CoV.
Okba N, Widjaja I, van Dieren B, Aebischer A, van Amerongen G, De Waal L
Emerg Microbes Infect. 2020; 9(1):1080-1091.
PMID: 32471334
PMC: 7448924.
DOI: 10.1080/22221751.2020.1760735.
Structural insights into coronavirus entry.
Tortorici M, Veesler D
Adv Virus Res. 2019; 105:93-116.
PMID: 31522710
PMC: 7112261.
DOI: 10.1016/bs.aivir.2019.08.002.
Tectonic conformational changes of a coronavirus spike glycoprotein promote membrane fusion.
Walls A, Tortorici M, Snijder J, Xiong X, Bosch B, Rey F
Proc Natl Acad Sci U S A. 2017; 114(42):11157-11162.
PMID: 29073020
PMC: 5651768.
DOI: 10.1073/pnas.1708727114.
Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen.
Pallesen J, Wang N, Corbett K, Wrapp D, Kirchdoerfer R, Turner H
Proc Natl Acad Sci U S A. 2017; 114(35):E7348-E7357.
PMID: 28807998
PMC: 5584442.
DOI: 10.1073/pnas.1707304114.
Cryo-electron microscopy structure of a coronavirus spike glycoprotein trimer.
Walls A, Tortorici M, Bosch B, Frenz B, Rottier P, DiMaio F
Nature. 2016; 531(7592):114-117.
PMID: 26855426
PMC: 5018210.
DOI: 10.1038/nature16988.
Mechanisms of coronavirus cell entry mediated by the viral spike protein.
Belouzard S, Millet J, Licitra B, Whittaker G
Viruses. 2012; 4(6):1011-33.
PMID: 22816037
PMC: 3397359.
DOI: 10.3390/v4061011.
Simultaneous detection of antibodies to mouse hepatitis virus recombinant structural proteins by a microsphere-based multiplex fluorescence immunoassay.
Kunita S, Kato K, Ishida M, Hagiwara K, Kameda S, Ishida T
Clin Vaccine Immunol. 2011; 18(5):758-66.
PMID: 21430123
PMC: 3122517.
DOI: 10.1128/CVI.00467-10.
Characterization of a highly conserved domain within the severe acute respiratory syndrome coronavirus spike protein S2 domain with characteristics of a viral fusion peptide.
Madu I, Roth S, Belouzard S, Whittaker G
J Virol. 2009; 83(15):7411-21.
PMID: 19439480
PMC: 2708636.
DOI: 10.1128/JVI.00079-09.
Monoclonal antibodies targeting the HR2 domain and the region immediately upstream of the HR2 of the S protein neutralize in vitro infection of severe acute respiratory syndrome coronavirus.
Lip K, Shen S, Yang X, Keng C, Zhang A, Janice Oh H
J Virol. 2005; 80(2):941-50.
PMID: 16378996
PMC: 1346840.
DOI: 10.1128/JVI.80.2.941-950.2006.
Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus.
Weiss S, Navas-Martin S
Microbiol Mol Biol Rev. 2005; 69(4):635-64.
PMID: 16339739
PMC: 1306801.
DOI: 10.1128/MMBR.69.4.635-664.2005.
Characterization of neutralizing monoclonal antibodies recognizing a 15-residues epitope on the spike protein HR2 region of severe acute respiratory syndrome coronavirus (SARS-CoV).
Lai S, Chong P, Yeh C, Liu L, Jan J, Chi H
J Biomed Sci. 2005; 12(5):711-27.
PMID: 16132115
PMC: 7089214.
DOI: 10.1007/s11373-005-9004-3.
Identification of previously unknown antigenic epitopes on the S and N proteins of avian infectious bronchitis virus.
Ignjatovic J, Sapats S
Arch Virol. 2005; 150(9):1813-31.
PMID: 15868095
PMC: 7087300.
DOI: 10.1007/s00705-005-0541-x.
Neutralizing antibodies in patients with severe acute respiratory syndrome-associated coronavirus infection.
Nie Y, Wang G, Shi X, Zhang H, Qiu Y, He Z
J Infect Dis. 2004; 190(6):1119-26.
PMID: 15319862
PMC: 7199490.
DOI: 10.1086/423286.
Identification of an antigenic determinant on the S2 domain of the severe acute respiratory syndrome coronavirus spike glycoprotein capable of inducing neutralizing antibodies.
Zhang H, Wang G, Li J, Nie Y, Shi X, Lian G
J Virol. 2004; 78(13):6938-45.
PMID: 15194770
PMC: 421668.
DOI: 10.1128/JVI.78.13.6938-6945.2004.
The N-terminal domain of the murine coronavirus spike glycoprotein determines the CEACAM1 receptor specificity of the virus strain.
Tsai J, Zelus B, Holmes K, Weiss S
J Virol. 2002; 77(2):841-50.
PMID: 12502800
PMC: 140794.
DOI: 10.1128/jvi.77.2.841-850.2003.